Top CFO Executive Search Firm in Chennai for Pharma & Biotech — 2026

Pharma finance in the Chennai and wider Tamil Nadu region is manufacturing-weighted — formulations, API, specialty pharma and contract manufacturing for global clients. The CFO mandate centres on regulated-manufacturing finance: a leader who can run cost and capex for USFDA- and WHO-GMP-grade facilities, manage quality-linked cost and remediation, fund capacity expansion, and support growth across India and export markets. CDMO businesses add client-contract and capacity economics under audit; specialty pharma adds R&D and commercial finance. The defining scarcity is the finance leader who pairs regulated-manufacturing cost-and-capex command with the capital fluency to fund growth and qualification.

Compensation is largely cash-led with performance pay and a modest equity element, reflecting promoter-led and MNC-subsidiary structures, with milestone or equity upside in venture-backed or listed settings. The brief sets which applies. The stakeholder map runs from promoters or global parents to regulators, auditors and CDMO clients. References reach to auditors, regulators and operating-finance leaders, because the question that decides these mandates — can this CFO fund and cost a regulated pharma business while protecting quality — is answered by those who have watched them run it.